Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Frauenkrankheiten (Gynäkologie)
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Bulgarien
  • Dänemark
  • Estland
  • Frankreich
  • Lettland
  • Spanien
  • Ukraine
  • Asien / Pazifik
  • China
  • Mittlerer Osten / Afrika
  • Iran
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012

GlobalData

GlobalData

2 / 2012
126 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

773,40 €*
( 1.000,00 $)
PDF-Datei per E-Mail, Single User Price , versandkostenfrei
1.546,79 €*
( 2.000,00 $)
PDF-Datei per E-Mail, Site License Price** , versandkostenfrei
2.320,19 €*
( 3.000,00 $)
PDF-Datei per E-Mail, Enterprisewide Price (Global Site License)*** , versandkostenfrei


Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, 'Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012' provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Post Menopausal Osteoporosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Post Menopausal Osteoporosis 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by BRIC Nations 17

Clinical Trials by G7 Nations 18

Clinical Trials in G7 Nations by Trial Status 19

Clinical Trials by E7 Nations 20

Clinical Trials in E7 Nations by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Unaccomplished Trials of Post Menopausal Osteoporosis 25

Subjects Recruited Over a Period of Time 27

Prominent Sponsors 28

Top Companies Participating in Post Menopausal Osteoporosis Therapeutics Clinical Trials 30

Prominent Drug Comparison 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Eli Lilly and Company 33

Clinical Trial Overview of Eli Lilly and Company 33

Merck & Co., Inc. 35

Clinical Trial Overview of Merck & Co., Inc. 35

F. Hoffmann-La Roche Ltd. 37

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37

Novartis AG 39

Clinical Trial Overview of Novartis AG 39

Amgen Inc. 41

Clinical Trial Overview of Amgen Inc. 41

GlaxoSmithKline plc 42

Clinical Trial Overview of GlaxoSmithKline plc 42

Sanofi 43

Clinical Trial Overview of Sanofi 43

Warner Chilcott Plc 44

Clinical Trial Overview of Warner Chilcott Plc 44

Pfizer Inc. 45

Clinical Trial Overview of Pfizer Inc. 45

Bayer AG 46

Clinical Trial Overview of Bayer AG 46

Fougera Pharmaceuticals Inc. 47

Clinical Trial Overview of Fougera Pharmaceuticals Inc. 47

Ligand Pharmaceuticals, Inc. 48

Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 48

Unigene Laboratories, Inc. 49

Clinical Trial Overview of Unigene Laboratories, Inc. 49

Warner Chilcott Company, Inc. 50

Clinical Trial Overview of Warner Chilcott Company, Inc. 50

Eisai Inc. 51

Clinical Trial Overview of Eisai Inc. 51

Radius Health, Inc. 52

Clinical Trial Overview of Radius Health, Inc. 52

Procter & Gamble Pharmaceuticals, Inc. 53

Clinical Trial Overview of Procter & Gamble Pharmaceuticals, Inc. 53

Tarsa Therapeutics, Inc. 54

Clinical Trial Overview of Tarsa Therapeutics, Inc. 54

Ascend Therapeutics, Inc. 55

Clinical Trial Overview of Ascend Therapeutics, Inc. 55

Zydus Cadila Healthcare Limited 56

Clinical Trial Overview of Zydus Cadila Healthcare Limited 56

Clinical Trial Overview of Top Universities / Institutes / Hospitals 57

University of Pittsburgh 57

Clinical Trial Overview of University of Pittsburgh 57

University of California, San Francisco 58

Clinical Trial Overview of University of California, San Francisco 58

Oregon Health and Science University 59

Clinical Trial Overview of Oregon Health and Science University 59

University Health Network 60

Clinical Trial Overview of University Health Network 60

The National Institute of Diabetes and Digestive and Kidney Diseases 61

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 61

McGill University Health Center 62

Clinical Trial Overview of McGill University Health Center 62

Creighton University 63

Clinical Trial Overview of Creighton University 63

Medical University of South Carolina 64

Clinical Trial Overview of Medical University of South Carolina 64

The University of Kansas 65

Clinical Trial Overview of The University of Kansas 65

University of Messina 66

Clinical Trial Overview of University of Messina 66

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 67

Clinical Trial Overview of INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 67

University of Wisconsin Madison 68

Clinical Trial Overview of University of Wisconsin Madison 68

Dana-Farber Cancer Institute 69

Clinical Trial Overview of Dana-Farber Cancer Institute 69

Kuopio University Hospital 70

Clinical Trial Overview of Kuopio University Hospital 70

Medical University of Vienna 71

Clinical Trial Overview of Medical University of Vienna 71

University of Tennessee 72

Clinical Trial Overview of University of Tennessee 72

Weill Cornell Medical College 73

Clinical Trial Overview of Weill Cornell Medical College 73

Emory University 74

Clinical Trial Overview of Emory University 74

Charite University 75

Clinical Trial Overview of Charite University 75

St. Michael's Hospital 76

Clinical Trial Overview of St. Michael's Hospital 76

Five Key Clinical Profiles 77

Appendix 123

Abbreviations 123

Definitions 123

Research Methodology 124

Secondary Research 125

About GlobalData 125

Contact Us 125

Disclaimer 125

Source 126



List of Tables

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13

Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries, 2012* 14

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16

Post Menopausal Osteoporosis Therapeutics Clinical Trials, BRIC Countries, 2012* 17

Post Menopausal Osteoporosis Therapeutics Clinical Trials, G7 Countries, 2012* 18

Post Menopausal Osteoporosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19

Post Menopausal Osteoporosis Therapeutics Clinical Trials, E7 Countries, 2012* 20

Post Menopausal Osteoporosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24

Post Menopausal Osteoporosis Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25

Post Menopausal Osteoporosis Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 33

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 35

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 37

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 39

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 41

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 42

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 43

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Warner Chilcott Plc, 2012* 44

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 46

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fougera Pharmaceuticals Inc., 2012* 47

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ligand Pharmaceuticals, Inc., 2012* 48

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Unigene Laboratories, Inc., 2012* 49

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Warner Chilcott Company, Inc., 2012* 50

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 51

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radius Health, Inc., 2012* 52

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Procter & Gamble Pharmaceuticals, Inc., 2012* 53

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tarsa Therapeutics, Inc., 2012* 54

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ascend Therapeutics, Inc., 2012* 55

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zydus Cadila Healthcare Limited, 2012* 56

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 57

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 58

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012* 59

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 60

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2012* 61

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2012* 62

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2012* 63

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2012* 64

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Kansas, 2012* 65

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Messina, 2012* 66

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by INSTITUT DE RECHERCHES INTERNATIONALES SERVIER, 2012* 67

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 68

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 69

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2012* 70

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 71

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tennessee, 2012* 72

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 73

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 74

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012* 75

Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Michael's Hospital, 2012* 76



List of Figures

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13

Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16

Post Menopausal Osteoporosis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17

Post Menopausal Osteoporosis Therapeutics Clinical Trials, G7 Countries (%), 2012* 18

Post Menopausal Osteoporosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19

Post Menopausal Osteoporosis Therapeutics Clinical Trials, E7 Countries (%), 2012* 20

Post Menopausal Osteoporosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23

Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30

Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32

GlobalData Methodology 124

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: